<DOC>
	<DOCNO>NCT02003417</DOCNO>
	<brief_summary>This study evaluate proportion prostate cancer patient receive external beam radiation therapy ( EBRT ) androgen deprivation therapy ( ADT ) control blood sugar ( fast glucose hemoglobin A1c ) , blood pressure , cholesterol profile ( total cholesterol , LDL , HDL , triglyceride ) baseline , 3 month , 12 month complete radiation treatment . In addition , receipt guideline-recommended cardiovascular , primary preventive care well patient-reported quality life satisfaction care among patient evaluate baseline 12 month .</brief_summary>
	<brief_title>Cardiovascular Risk Preventive Care Prostate Cancer Patients Receiving Radiation Hormone Therapy</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>Histologicallyconfirmed , nonmetastatic prostate cancer Patients receive external beam radiation treatment androgen deprivation therapy ( total ADT duration &gt; 3 month ) curative treatment , either definitive postprostatectomy set Patients primary care provider Informed consent obtain signed Ability read write English Age &gt; = 18 No mental incompetence would preclude completion questionnaire Prior cancer , pelvic radiation treatment chemotherapy Patients primary care provider Prior ADT Mental incompetence would preclude completion questionnaire Unable read write English</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>External beam radiation treatment</keyword>
	<keyword>Androgen deprivation therapy</keyword>
	<keyword>Definitive treatment</keyword>
	<keyword>Cardiovascular risk factor</keyword>
	<keyword>Quality life</keyword>
</DOC>